SCHEMBL7862739

SCHEMBL7862739

CCOCCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(OC(=O)NCCOC)nc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
KMT2A Q03164 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 3/20 0.44
MAPT P10636 1/20 0.44
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
EGFR P00533 2/20 0.41
P4HTM Q9NXG6 1/20 0.41
EGLN1 Q9GZT9 1/20 0.41
NAMPT P43490 1/20 0.40
GABRA5 P31644 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7874619 0.96 HPGD (0.47) HPGDSMN1; SMN2KMT2AL3MBTL1RAB9A
SCHEMBL7869460 0.95 EGFR (0.43) HPGDSMN1; SMN2KMT2AL3MBTL1RAB9A
SCHEMBL9574842 0.95 EGFR (0.43) HPGDSMN1; SMN2KMT2AL3MBTL1RAB9A
SCHEMBL7870463 0.93 KMT2A (0.46) HPGDSMN1; SMN2KMT2AL3MBTL1RAB9A
SCHEMBL7867703 0.93 EGFR (0.45) HPGDSMN1; SMN2KMT2AL3MBTL1RAB9A
SCHEMBL7867827 0.92 KMT2A (0.42) HPGDSMN1; SMN2KMT2AL3MBTL1RAB9A
SCHEMBL7869442 0.92 EGFR (0.43) HPGDKMT2AL3MBTL1ALDH1A1KDM4E
SCHEMBL7867912 0.92 EGFR (0.47) HPGDSMN1; SMN2KMT2ARAB9ANPC1
SCHEMBL7871556 0.90 CA2 (0.47) HPGDSMN1; SMN2KMT2AL3MBTL1RAB9A
SCHEMBL7862801 0.90 CA2 (0.48) HPGDL3MBTL1ALDH1A1KDM4EEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed